CORRESP Filing
Shuttle Pharmaceuticals Holdings, Inc.
Date: Aug. 8, 2025 · CIK: 0001757499 · Accession: 0001641172-25-022787
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289231
Letter
VIA EDGAR Division of Corporation Finance Office of Trade & Services Attention: Mr. Tyler Howes Re: Shuttle Pharmaceuticals Holdings, Inc. Registration Statement on Form S-1 Filed August 5, 2025 File No. 333-289231
Dear Mr. Howes,
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), Shuttle Pharmaceuticals Holdings, Inc. (the "Company") respectfully requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1 (the "Registration Statement") and declare such Registration Statement effective at 4:30 p.m., Eastern Standard Time, on Monday, August 11, 2025, or as soon thereafter as practicable.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Jeff Cahlon, Esq. of Sichenzia Ross Ference Carmel at 212-930-9700.
* * * *
Very
Truly Yours,
Shuttle
Pharmaceuticals Holdings, Inc.
Show Raw Text
CORRESP 1 filename1.htm SHUTTLE PHARMACEUTICALS HOLDINGS, INC. 401 Professional Drive, Suite 260 Gaithersburg, MD 20879 August 8, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. Tyler Howes Re: Shuttle Pharmaceuticals Holdings, Inc. Registration Statement on Form S-1 Filed August 5, 2025 File No. 333-289231 Dear Mr. Howes, Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), Shuttle Pharmaceuticals Holdings, Inc. (the "Company") respectfully requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1 (the "Registration Statement") and declare such Registration Statement effective at 4:30 p.m., Eastern Standard Time, on Monday, August 11, 2025, or as soon thereafter as practicable. It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform Jeff Cahlon, Esq. of Sichenzia Ross Ference Carmel at 212-930-9700. * * * * Very Truly Yours, Shuttle Pharmaceuticals Holdings, Inc. /s/ Christopher Cooper Christopher Cooper Chief Executive Officer cc: Jeff Cahlon, Esq.